Evidence-based Respiratory Medicine

First major evidence-based text in adult respiratory medicine Comprehensive, authoritative summary of the best treatments for the major respiratory diseases Compiled by specialists from the Cochrane Airways Management Group Easy-to-use format, with key clinical implications summarised in each chapter Kept up-to-date online Compiled by specialists from the Cochrane Collaboration Airways Management Group, Evidence-based Respiratory Medicine is the first major evidence-based text in adult respiratory medicine. Providing a comprehensive summary of the best treatments for the most important respiratory diseases, some of the world's leading physicians review the evidence for a broad range of treatments using evidence-based principles. Essential information is presented in an easy-to-understand format, with the most important clinical implications summarised in each chapter. Evidence-based Respiratory Medicine tackles the big clinical questions in diagnosis and treatment, presenting treatment options which take into account the individual patient's needs. Evidence-Based Series:Evidence-based Respiratory Medicine, part of the acclaimed series BMJ Evidence-based medicine textbooks that have revolutionised clinical medicine literature, comes with a fully searchable CD-ROM of the whole text. Note: CD-ROM/DVD and other supplementary materials are not included as part of eBook file.Content: Chapter 1.1 Introduction (pages 1–10): Brian H Rowe and Terry P KlassenChapter 1.2.1 Diagnostic Strategies (pages 12–23): Michael AbramsonChapter 1.2.2 Diagnostic Strategies (pages 25–35): David P Johns and Alan J CrockettChapter 1.2.3 Diagnostic Strategies (pages 37–62): Johny A VerschakelenChapter 1.2.4 Diagnostic Strategies (pages 63–79): Martin RiedelChapter 1.2.5 Diagnostic Strategies (pages 81–87): John K Gohagan, Pamela M Marcus, Richard M Fagerstrom, William C Black, Barnett S Kramer, Paul F Pinsky and Philip C ProrokChapter 1.3.1 Therapeutics: General Issues (pages 89–105): Liesl M Osman and Michael E HylandChapter 1.3.2 Therapeutics: General Issues (pages 107–114): Michael L Burr and Michael StoneChapter 1.3.3 Therapeutics: General Issues (pages 115–120): Tim LancasterChapter 2.1 Acute Exacerbations (pages 121–133): Brian H RoweChapter 2.2 Chronic Therapy: ??Agonists, Short?Acting, Long?Acting ?2?Agonists (pages 135–145): Haydn Walters and Julia WaltersChapter 2.3 Inhaled Corticosteroids in the Treatment of Asthma (pages 147–167): Nick AdamsChapter 2.4 Anti?Leukotrienes (pages 169–182): Francine M DucharmeChapter 2.5 Asthma Education (pages 183–191): Peter G Gibson and Heather PowellChapter 2.6 Non?Pharmacological and Complementary Interventions to Manage Asthma (pages 193–204): Guy B Marks, Brett G Toelle and Cassandra A SladerChapter 2.7 Difficult Asthma (pages 205–216): Peter A B WarkChapter 2.8 Novel Therapies in Asthma: Long?Acting ?2?Agonists Inhaled Corticosteroids (pages 217–230): Nicola A Marks and Philip W IndChapter 3.1 Chronic Obstructive Pulmonary Disease ? Acute Exacerbations (pages 231–243): Brian H Rowe and Irvin MayersChapter 3.2 Anticholinergic Bronchodilators in Chronic Obstructive Pulmonary Disease Therapy (pages 245–256): Alicia R ZuWallack and Richard L ZuWallackChapter 3.3 Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease (pages 257–266): Christine JenkinsChapter 3.4 Combination of Inhaled Corticosteroids and Long?Acting ?2?Agonists in Chronic Obstructive Pulmonary Disease (pages 267–276): Paul W JonesChapter 3.5 Systemic Corticosteroids in Stable Chronic Obstructive Pulmonary Disease (pages 277–284): Richard Wood?BakerChapter 3.6 Lung Volume Reduction (pages 285–297): Tudor P Toma and Duncan M GeddesChapter 4.1 Bronchitis and Sinusitis (pages 299–308): Tom FaheyChapter 4.2 Community?Acquired Pneumonia (pages 309–319): Jihendra N Pande, Juhi Dhar and G SowmyaChapter 4.3 Pulmonary Tuberculosis (pages 321–333): Jimmy Volmink and Colleen MurphyChapter 4.4 Influenza: Vaccination and Treatment (pages 335–347): Fotini B Karassa and John P A IoannidisChapter 4.5 Bronchiectasis (pages 349–360): John KolbeChapter 4.6 Adult Cystic Fibrosis (pages 361–388): John KolbeChapter 4.7 Antibiotics in Chronic Obstructive Pulmonary Disease, Bronchiectasis and Cystic Fibrosis (pages 389–413): Ian A Yang, Samuel T Kim and Scott C BellChapter 5.1 Respiratory Rehabilitation (pages 415–428): Yves Lacasse, Francois Maltais and Roger S GoldsteinChapter 5.2 Non?Invasive Ventilation in Acute Respiratory Failure (pages 429–438): Peter WarkChapter 5.3 Non?Invasive Positive Pressure Ventilation in Stable Patients with Chronic Obstructive Pulmonary Disease. What is the Evidence? (pages 439–446): Peter J WijkstraChapter 5.4 The Treatment of the Obstructive Sleep Apnoea?Hypopnoea Syndrome (pages 447–461): Michael J Hensley and Cheryl D RayChapter 5.5 Long?Term Oxygen Therapy for Chronic Respiratory Failure in Chronic Obstructive Pulmonary Disease (pages 463–471): Peter G GibsonChapter 6.1.1 Diffuse Lung Disease (pages 473–489): Barry Plant and Jim EganChapter 6.1.2 Diffuse Lung Disease (pages 491–508): Robert P Baughman and Olof SelroosChapter 6.1.3 Diffuse Lung Disease (pages 509–520): Yves Lacasse and Yvon CormierChapter 6.2 Pleural Disease (pages 521–536): Richard LightChapter 6.3 Therapy of Pulmonary Thromboembolism: an Evidence?Based Approach (pages 537–558): Martin RiedelChapter 6.4 Pulmonary Hypertension (pages 559–571): Horst Olschewski